The rationale and potential of cancer chemoprevention with special emphasis on breast cancer.
Puntoni
Matteo
M
Medical Oncology Unit, Galliera Hospital, Genoa, Italy.
Decensi
Andrea
A
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000517:prevention & control*; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012176:Retinoids / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D012176:Retinoids; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride